Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?

Affiliations

Editorial

Judy Savige. Kidney Int Rep. 2018.

. 2018 Aug 22;3(6):1239-1241.

doi: 10.1016/j.ekir.2018.08.002. eCollection 2018 Nov.

¹ Department of Medicine (Melbourne Health) and Northern Health, The University of Melbourne, Parkville, Victoria, Australia.

No abstract available

References

1. Ciccarese M., Casu D., Ki Wong F. Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia. Nephrol Dial Transplant. 2001;16:2008–2012. - PubMed
1. Deng S., Xu H., Yuan J. Identification of a novel collagen type IV alpha-4 (COL4A4) mutation in a Chinese family with autosomal dominant Alport syndrome using exome sequencing. Indian J Med Res. 2016;144:200–205. - PMC - PubMed
1. Imafuku A., Nozu K., Sawa N. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically. Nephrology (Carlton) 2018;23:940–947. - PMC - PubMed
1. Pescucci C., Mari F., Longo I. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int. 2004;65:1598–1603. - PubMed
1. Rosado C., Bueno E., Felipe C., Gonzalez-Sarmiento R. COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome. Int J Mol Epidemiol Genet. 2014;5:177–184. - PMC - PubMed